Head Office Oxford

CEO Dr Holly Reeve

CSO Dr Sarah Cleary

CGF Board Rep Susannah McClintock

HydRegen is pioneering the production of bio-based catalysts that enable cleaner, safer and more energy-efficient manufacturing processes for the global pharmaceutical and chemicals industries. Their innovative biotechnology aims to deliver huge CO₂ savings and operating costs by replacing toxic metal catalysts with environmentally and economically friendly bio-based alternatives.

Picture credits: www.charlieflounders.com